Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 15, 2026 · Filed Oct 20, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
option exercise
Code M — exercise or conversion of a derivative security
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Insider buying
First insider buy since May 2025Traded Nov 10 · filed 3 days later
An Ionis Pharmaceuticals director paid $148K out of pocket for Ionis Pharmaceuticals shares. It was the first purchase in 18 months. Shares held went up 23% with this purchase.
Fund moves
From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Eric Swayze (EVP Research) sold ~$2.3K of Ionis Pharmaceuticals
Automatic saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.